Today

Agents

Chat

Arena

Discover

More

App

Xylem Q2 Revenue USD 2,300 Million Vs. IBES Estimate USD 2,341 Million - XYL News | Rallies

Xylem Q2 Revenue USD 2,300 Million Vs. IBES Estimate USD 2,341 Million

XYL•2026-07-28

Q2 results and outlook

Jul 28 (Reuters) - Xylem Q2 adjusted net income USD 345 million vs. IBES estimate USD 323.7 million.

Q2 adjusted EPS USD 1.46 vs. IBES estimate USD 1.34
Q2 EPS USD 1.11
outlook FY adjusted EBITDA margin 23.1-23.5%

Related News

Kiniksa Pharmaceuticals Q2 product revenue rises on ARCALYST sales

KNSA•2026-07-28

Vistra Corp <VST.N>: Raymond James cuts target price to $186 from $202

VST•2026-07-28

Tesla To Buy Power From KKR-Backed Arizona Solar, Battery Plant

2026-07-28

Universal Health falls after profit forecast cut

UHS•2026-07-28

SNAPSHOT-India stocks, rupee, swaps, call at close

SPY•2026-07-28